Skip to content
HowShorted

Biocept, Inc. short interest in 2021

In 2021, Biocept, Inc.'s disclosed short interest ran from 3.13% of shares outstanding on 15 Jan 2021 to 2.38% on 31 Dec 2021, a change of -0.75 percentage points. The year's high was 6.67% on 15 Sep 2021 and its low 2.21% on 15 Dec 2021, averaging 4.39% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.39 days on 28 May 2021. Full history: Biocept, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Biocept, Inc. in 2021

2021 in figures

Start of year
3.13% (15 Jan 2021)
End of year
2.38% (31 Dec 2021)
Change
-0.75 pp
High
6.67% (15 Sep 2021)
Low
2.21% (15 Dec 2021)
Average
4.39%
Highest days to cover
5.39 (28 May 2021)
SEC filings marked
8

Every report in 2021

Biocept, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.13%1.01
29 Jan 20213.36%1.00
12 Feb 20212.81%1.00
26 Feb 20212.90%1.02
15 Mar 20214.29%1.70
31 Mar 20216.61%1.09results (8-K), 10-K filed
15 Apr 20215.78%2.22
30 Apr 20215.39%2.93
14 May 20215.82%3.7910-Q filed, results (8-K)
28 May 20214.43%5.39
15 Jun 20214.89%3.15
30 Jun 20215.05%1.00
15 Jul 20216.23%2.89
30 Jul 20215.83%1.64
13 Aug 20215.08%3.57
31 Aug 20216.59%1.0010-Q filed, results (8-K)
15 Sep 20216.67%2.63
30 Sep 20213.31%1.53
15 Oct 20213.82%1.41
29 Oct 20213.14%3.18
15 Nov 20212.42%2.2210-Q filed, results (8-K)
30 Nov 20213.12%1.88
15 Dec 20212.21%1.00
31 Dec 20212.38%2.37

See also: Biocept, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.